A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Clinical trial NCT05914116 · RECRUITING

Trial details

NCT number: NCT05914116
Sponsor: DualityBio Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-08-17
Primary completion: 2027-12-01
Enrollment: 862

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.